Targeting synaptic calcium permeable receptors in the nucleus accumbens and blocking them could delay or prevent the onset of Alzheimer's associated neuropsychiatric symptoms, and ultimately cognitive decline.
Targeting synaptic calcium permeable receptors in the nucleus accumbens and blocking them could delay or prevent the onset of Alzheimer's associated neuropsychiatric symptoms, and ultimately cognitive decline.